Jack G. Copeland
Keine laufenden Positionen mehr
Profil
Jack G.
Copeland was the founder of SynCardia Systems LLC (founded in 2001) and International Society for Heart & Lung Transplantation (founded in 1981) where he held the titles of Director and President respectively.
He held the position of Professor at the University of Arizona from 1977 to 2010 and at the University of California San Diego from 2010 to 2014.
He also worked as a Clinical Associate at the National Heart, Lung & Blood Institute.
Dr. Copeland received his undergraduate degree from Stanford University and his doctorate from Stanford University School of Medicine.
Ehemalige bekannte Positionen von Jack G. Copeland
| Unternehmen | Position | Ende |
|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 01.06.2014 |
| University of Arizona | Corporate Officer/Principal | 01.01.2010 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | - |
| International Society for Heart & Lung Transplantation | Gründer | - |
SynCardia Systems LLC
 SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Gründer | - |
Ausbildung von Jack G. Copeland
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
SynCardia Systems LLC
SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Health Technology |
| International Society for Heart & Lung Transplantation | |
| National Heart, Lung & Blood Institute | Government |
